Area of research
Genetics · Hematology
Research interest
Research interests include Medicine, Internal medicine, Disease, Anemia, Cardiology, and Intensive care medicine.
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international <scp>Sickle Cell World Assessment Survey</scp> (<scp>SWAY</scp>)
Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The <scp>PUSH</scp> study
The <scp><i>CYB5R3</i><sup>c</sup></scp><sup>.<scp>350C</scp>>G</sup> and <scp><i>G6PD</i></scp> A alleles modify severity of anemia in malaria and sickle cell disease
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings
A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease
Activated STING in a Vascular and Pulmonary Syndrome
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)
Silent cerebral infarction, income, and grade retention among students with sickle cell anemia
Mortality analysis by neighbourhood in a city with high levels of industrial air pollution
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease
IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies
Abnormal Pulmonary Function and Associated Risk Factors in Children and Adolescents With Sickle Cell Anemia
Genetic determinants of haemolysis in sickle cell anaemia
Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two‐year results including pharmacokinetics and concomitant hydroxyurea
Clinical correlates of acute pulmonary events in children and adolescents with sickle cell disease
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans